US-based medical device company Penumbra has commercially introduced its thrombectomy device, the ACE 68 Reperfusion Catheter in the US.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The catheter is based on the latest technology to offer maximum aspiration power in an easy and safe way for extracting thrombus in acute ischemic stroke patients.

The device features a coil winding geometry along 16 transitions to promote an optimum tracking profile which is done through tortuosity characterising an acute ischemic stroke in patients.

It is designed to extract the clot quickly and effectively as a part of the Penumbra system.

Semmes-Murphey Neurologic & Spine Institute Department of Neurosurgery, UTHSC professor Adam Arthur said: “The ACE68 provides an opportunity to reverse strokes faster and with less expense.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“The larger lumen seems to allow better clot capture, which may reduce the need for adjunctive devices, simplify the procedure and reduce procedure cost important considerations as hospitals look to expand stroke services.”

The ACE68 Reperfusion Catheter is a part of the fully integrated Penumbra System used for revascularisation of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease after displaying of symptom within eight hours.

"The early reports from physicians on the performance of ACE68 confirm that this is the most impactful stroke product we have ever developed."

Penumbra chairman and chief executive officer Adam Elsesser said: "We designed the ACE68 with the intent to make real improvement on stroke procedure time, outcome and cost.

"The early reports from physicians on the performance of ACE68 confirm that this is the most impactful stroke product we have ever developed."

The Penumbra System is integrated with large, highly pliable and trackable Reperfusion Catheters that leverages on the full aspiration power of the Penumbra Pump MAX within an integrated, patented system to eliminate chances of the stroke-causing occlusion safely and effectively.


Image: The ACE6 8 Reperfusion Catheter. Photo: courtesy of Penumbra.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact